Lifeday coverage of oral anticoagulants and one-year relative survival in patients with atrial fibrillation: a population-based study in Estonia

BACKGROUND: Routine oral anticoagulation (OAC) is recommended for almost all high-risk patients with atrial fibrillation, yet registries show that OACs are still underused. Our aim was to study the lifeday coverage (LDC) of OAC prescriptions and its relationship with one-year mortality rates of AF p...

Descripción completa

Detalles Bibliográficos
Autores principales: Pauklin, Priit, Marandi, Toomas, Kals, Mart, Ainla, Tiia, Martinson, Katrin, Eha, Jaan, Kampus, Priit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422845/
https://www.ncbi.nlm.nih.gov/pubmed/37568101
http://dx.doi.org/10.1186/s12872-023-03415-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422845/
https://www.ncbi.nlm.nih.gov/pubmed/37568101
http://dx.doi.org/10.1186/s12872-023-03415-4

Ejemplares similares